Embecta Corp

NASDAQ EMBC

Download Data

Embecta Corp Accounts Receivable Turnover Ratio 3 year CAGR for the Trailing 12 Months (TTM) ending March 31, 2024

Embecta Corp Accounts Receivable Turnover Ratio 3 year CAGR is NA for the Trailing 12 Months (TTM) ending March 31, 2024. The accounts receivable turnover ratio measures the efficiency of a company in collecting payments from its customers. It is calculated by dividing the company's revenue by its accounts receivable. This ratio provides insight into how quickly a company collects outstanding funds owed to it. A higher turnover ratio implies that the company efficiently converts credit sales into cash, while a lower ratio may indicate delays in collecting payments or potential issues with credit management. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
  • Embecta Corp Accounts Receivable Turnover Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was 2.06, a -72.51% change year over year.
  • Embecta Corp Accounts Receivable Turnover Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was 7.50.
NASDAQ: EMBC

Embecta Corp

CEO Mr. Devdatt Kurdikar
IPO Date April 1, 2022
Location United States
Headquarters 300 Kimball Drive, Parsippany, NJ, United States, 07054
Employees 2,200
Sector Healthcare
Industry Medical instruments & supplies
Description

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Similar companies

ANGO

AngioDynamics Inc

NA

NA

AKYA

Akoya Biosciences Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email